CC-4047-MMM-001
Showing 1 - 25 of 1,523
Polycythemia Vera, Thrombocythemia Trial in Houston (CC-4047, Prednisone)
Completed
- Polycythemia Vera
- Thrombocythemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 5, 2019
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New Haven, Connecticut
- +23 more
Aug 1, 2022
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
-
Borddeaux Cedex, France
- +9 more
Nov 11, 2022
Healthy Volunteer Trial in Madison (CC-90009, [14C])
Completed
- Healthy Volunteer
- CC-90009
- [14C]
-
Madison, WisconsinCovance Clinical Research Unit Inc.
Dec 15, 2021
Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis Trial in Worldwide (Pomalidomide, Prednisone, Placebo
Completed
- Myelofibrosis With Myeloid Metaplasia
- +2 more
- Pomalidomide
- +3 more
-
Los Angeles, California
- +10 more
Nov 7, 2019
Kidney Transplant Trial in Canada, United States (Abatacept, Standard of Care at US Transplant Centers)
Not yet recruiting
- Kidney Transplant
- Abatacept
- Standard of Care at US Transplant Centers
-
Birmingham, Alabama
- +19 more
Jun 20, 2023
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Pomalidomide
- +3 more
-
Basking Ridge, New Jersey
- +9 more
Jan 23, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023
Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))
Completed
- Safety
- +2 more
- RHN-001 (one tablet 750mg)
- RHN-001 (750mg * 2 Tablets)
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)
Recruiting
- Advanced Solid Tumor
- B4T2-001 autologous CAR-T
-
Shanghai, China/Shanghai, China
- +1 more
Oct 3, 2023
l Gene Editing Therapy for Cardiovascular Disease
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Auckland, New Zealand
- +2 more
Oct 31, 2023
Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,
Completed
- Meibomian Gland Dysfunction
- Dry Eye
- AZR-MD-001 Low Dose
- +3 more
-
Chatswood, New South Wales, Australia
- +29 more
Nov 23, 2022